Literature DB >> 12441085

Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.

Edward Trybala1, Anette Roth, Maria Johansson, Jan-Ake Liljeqvist, Elham Rekabdar, Olle Larm, Tomas Bergström.   

Abstract

Adaptation of some viruses to replication in cultured cells selects variants that due to alterations in the viral attachment proteins convert to using heparan sulfate (HS) as initial receptor. We report that the nucleotide sequence of herpes simplex virus type 1 (HSV-1) glycoprotein C (gC), a principal attachment component of the virus, remained unchanged during adaptation of wild-type strains to cultured cells. Likewise, amino acid residues critical for binding of gC to HS were conserved in viral strains that replicated in vivo in different human tissues. Moreover wild-type HSV-1 strains derived directly from clinical specimens were, similar to their cell culture propagated progeny viruses and common laboratory strains, sensitive to heparin and demonstrated impairment in their ability to infect HS/chondroitin sulfate deficient cells. These results demonstrate that the HS-binding ability is a feature of wild-type strains of HSV-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441085     DOI: 10.1006/viro.2002.1639

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

2.  Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses.

Authors:  Kate D Ryman; Christina L Gardner; Crystal W Burke; Kathryn C Meier; Joseph M Thompson; William B Klimstra
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.

Authors:  Vaibhav Tiwari; Jian Liu; Tibor Valyi-Nagy; Deepak Shukla
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

Review 4.  Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.

Authors:  Aswani D Vadlapudi; Ramya K Vadlapatla; Ashim K Mitra
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-04

5.  Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses.

Authors:  Peter Norberg; Tomas Bergström; Elham Rekabdar; Magnus Lindh; Jan-Ake Liljeqvist
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α.

Authors:  Sona Chowdhury; Misagh Naderi; Vladimir N Chouljenko; Jason D Walker; Konstantin G Kousoulas
Journal:  Virol J       Date:  2012-06-13       Impact factor: 4.099

7.  Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification.

Authors:  Anusha Harishankar; Malathi Jambulingam; Raajaram Gowrishankar; Annapoorni Venkatachalam; Umashankar Vetrivel; Sathyabaarathi Ravichandran; Samson Moses Yesupadam; Hajib Narahari Rao Madhavan
Journal:  Virol J       Date:  2012-03-14       Impact factor: 4.099

8.  Heparan sulfate proteoglycan: an arbovirus attachment factor integral to mosquito salivary gland ducts.

Authors:  Kristen A Ciano; Jason J Saredy; Doria F Bowers
Journal:  Viruses       Date:  2014-12-22       Impact factor: 5.048

9.  Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.

Authors:  Dhiraj Acharya; Amber M Paul; John F Anderson; Faqing Huang; Fengwei Bai
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

10.  Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate.

Authors:  Agostina Pietrantoni; Claudia Fortuna; Maria Elena Remoli; Maria Grazia Ciufolini; Fabiana Superti
Journal:  Viruses       Date:  2015-01-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.